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Summary
Nephropathic cystinosis is an autosomal recessive dis-
order that is characterized by accumulation of intraly-
sosomal cystine and is caused by a defect in the transport
of cystine across the lysosomal membrane. Using a po-
sitional cloning strategy, we recently cloned the causative
gene, CTNS, and identified pathogenic mutations, in-
cluding deletions, that span the cystinosis locus. Two
types of deletions were detected—one of 9.5–16 kb,
which was seen in a single family, and one of ∼65 kb,
which is the most frequent mutation found in the ho-
mozygous state in nearly one-third of cystinotic individ-
uals. We present here characterization of the deletion
breakpoints and demonstrate that, although both dele-
tions occur in regions of repetitive sequences, they are
the result of nonhomologous recombination. This type
of mechanism suggests that the ∼65-kb deletion is not
a recurrent mutation, and our results confirm that it is
identical in all patients. Haplotype analysis shows that
this large deletion is due to a founder effect that occurred
in a white individual and that probably arose in the
middle of the first millenium. We also describe a rapid
PCR-based assay that will accurately detect both ho-
mozygous and heterozygous deletions, and we use it to
show that the ∼65-kb deletion is present in either the
homozygous or the heterozygous state in 76% of cys-
tinotic patients of European origin.
Received March 11, 1999; accepted for publication May 25, 1999;
electronically published July 7, 1999.
Address for correspondence and reprints: Dr. Corinne Antignac,
INSERM U423, Tour Lavoisier 6e e´tage, Hoˆpital Necker-Enfants
Malades 149, rue de Se`vres, 75015 Paris, France. E-mail: antignac
@necker.fr
 1999 by The American Society of Human Genetics. All rights reserved.
0002-9297/99/6502-0011$02.00
Introduction
Nephropathic cystinosis (MIM 219800), an autosomal
recessive disorder, is the most common inherited cause
of proximal renal tubular dysfunction (the renal Fanconi
syndrome) and is due to defective lysosomal transport
of cystine (Gahl et al. 1982). Affected individuals typi-
cally present with symptoms of severe fluid and electro-
lyte disturbance (polyuria and polydypsia, vomiting,
poor growth, and rickets) at age 6–12 mo. Without spe-
cific treatment, increasing growth retardation occurs,
with end-stage renal failure by age ∼10 years (Gahl et
al. 1995). After renal transplantation, cystine continues
to accumulate in other organs, leading to multisystem
disease. The cystinosis locus was mapped to the short
arm of chromosome 17 (The Cystinosis Collaborative
Research Group 1995), and, using a positional cloning
strategy, we recently cloned the causative gene, CTNS
(Town et al. 1998). The CTNS gene encodes a protein
of 367 amino acids, cystinosin, which is predicted to be
an integral lysosomal membrane protein. The identifi-
cation of CTNS was greatly facilitated by the detection
of deletions spanning the cystinosis locus in affected in-
dividuals. Two types of deletions were detected—one of
∼65 kb, which is found in the homozygous state in nearly
one-third of cystinotic individuals; and a smaller one of
9.5–16 kb, carried by a single family. Both the larger
deletion and the smaller one span the 5′ end of CTNS,
covering exons 1–10 and 1–3, respectively, and STS
analysis indicated that the larger deletion was the same
size in all patients. In this study, we characterize the
deletion breakpoints and describe a rapid, PCR-based
assay to detect both homozygous and heterozygous de-
letions. Our results confirm that the ∼65-kb deletion is
identical in all patients and suggest an ancient, common
ancestry for this mutation.
Subjects and Methods
Patients
We studied 167 individuals, from 147 families, with
nephropathic cystinosis. The families were divided into
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two cohorts. The first group of 67 families, with 84
patients, comprised families for which the STS content
of the CTNS region had been studied, and haplotype
analysis was done by means of polymorphic markers
flanking the CTNS locus. Thirty-nine of these unrelated
individuals were homozygous or heterozygous for the
large deletion and one (family P11) was apparently ho-
mozygous for the smaller deletion (Town et al. 1998).
The second cohort of 80 families, consisting of 83 pa-
tients, comprised unstudied cases of nephropathic cys-
tinosis. Informed consent was obtained from all indi-
viduals or their parents. The patients were from a variety
of ethnic groups. The majority (83%) were of European
origin, but 10 were from North Africa, 3 were from the
Middle East, 4 were from Pakistan, 3 were from Turkey,
1 was from South Africa, and 4 were of unknown origin.
Haplotype Analysis, Allelic Association, and Dating of
the Mutation
Genomic DNA was amplified with fluorescently
labeled primers corresponding to the microsatellite
loci D17S1528, D17S1798, D17S2167, D17S829,
D17S1828, and D17S1876. Primer sequences, PCR am-
plification, gel electrophoresis, and data analysis were
done as described elsewhere (The Cystinosis Collabo-
rative Research Group 1995; Dib et al. 1996; McDowell
et al. 1996). Statistical comparison of allele frequencies
between deleted and control chromosomes was made on
the basis of a x2 test for a 2 # 2 table, with alleles
classified into two groups, one for an allele potentially
associated with the deletion and one for all others com-
bined into a single group. The age of the deletion was
estimated by use of a simple approach that looked at
only a single mutation and that reconstructed likely an-
cestral recombinants (Risch et al. 1995). Assuming that
g generations have elapsed since the deletion occurred
on a sole chromosome with an original associated allele
at a locus close to the deletion locus, then 1 pD 
, where v is the recombinationg[1 (1 v) ] (1 pN)
fraction between the two loci, pD the frequency of the
associated allele on deleted chromosomes, and pN the
frequency for that allele on control chromosomes (Risch
et al. 1995); hence, g may be estimated.
Southern Blot Analysis
Genomic DNA from affected individuals was digested
by HindIII and hybridized with a CTNS cDNA probe
spanning the whole coding sequence as well as 286 bp
and 1134 bp of the 5′ and 3′ untranslated regions, re-
spectively. Southern blotting and hybridizations were
performed as described elsewhere (Antignac et al. 1992).
PCR Amplification and Direct Sequencing
Primer sequences and PCR conditions were selected
with the OLIGO 5.0 program (NBI). The primers, span-
ning the breakpoints of the ∼65-kb deletion (65A–65A.1
and 65A–65A.2), and the P11 deletion (P11.1–P11.2)
were as follows: 65A, 5′-CCGGAGTCTACAGGGCA-
CAG-3′; 65A.1: 5′-GTCCCGGCTCACCCTCTTCC-3′,
65.A2: 5′-GGCCATGTAGCTCTCACCTC-3′; P11.1: 5′-
AAGGGCAGAATGAGGTTGGA-3′; P11.2: 5′-AAG-
GGCAGCAAGGCACTCGT-3′. After denaturation at
94C for 5 min, amplification was done with 30 cycles
of 1 min at 94C, 1 min at the annealing temperature
of 58C, and 1 min at 72C, with a final extension step
of 5 min at 72C. PCR products were purified by means
of the Wizard PCR Preps DNA-purification System (Pro-
mega) and were directly sequenced by use of an Applied
Biosystems DNA sequencer (model 373A) and the
BigDyeTM terminator cycle sequencing kit (Perkin-El-
mer), according to the manufacturer’s protocol. All se-
quences were analyzed with BLAST programs (Altschul
et al. 1990) after identification and masking of repetitive
sequences with the program RepeatMasker (Smit 1996).
Results
Haplotypes
Initially, DNA from 41 unrelated patients and their
families was typed with six microsatellite loci, which
span the cystinosis locus and cover a 5-cM interval of
the short arm of chromosome 17. Strong linkage dis-
equilibrium with a cystinosis mutation was not observed
for any haplotype across this region, and linkage dise-
quilibrium was not found with the flanking marker
D17S2167. However, in the European families, a 215-
bp allele of the other flanking marker D17S1828 was
observed more frequently on chromosomes carrying the
∼65-kb deletion than on chromosomes from unaffected
family members. We therefore typed an additional 25
patients and their families with the D17S1828 marker.
To establish haplotypes and to observe the frequency of
recombination across the CTNS region, we also typed
these 25 families with D17S2167 and with D17S829,
which is intragenic. The results with marker D17S1828
are shown (table 1) for a total of 117 chromosomes
carrying known CTNS mutations. Of these, 98 were
from European individuals and 19 were from individuals
from other ethnic groups. The control (noncystinotic)
chromosomes were those withoutCTNSmutations from
the carrier parents. The 215-bp allele of marker
D17S1828was detected on 26.7% of our European con-
trol chromosomes (23 of 86) and on 21.8% of 261 un-
related CEPH chromosomes. The frequency of this allele
on chromosomes with the large CTNS deletion was sig-
nificantly higher (46.3%), giving a P value of .0004.
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Figure 1 Southern blot analysis of HindIII-digested DNA hy-
bridized with a full-length CTNS cDNA probe. A, DNA from indi-
viduals with homozygous (lanes 1 and 2) and heterozygous (lanes 3
and 4) deletions for the ∼65-kb deletion and from control individuals
(lanes 5 and 6). B, DNA from patient P11 (lane 1) and control indi-
viduals (lanes 2 and 3).
Table 1
Frequency of the 215-bp Allele of Marker D17S1828
CHROMOSOME ORIGIN AND ALLELE
NO. OF CYSTINOTIC
CHROMOSOMES
NO. OF NON-
CYSTINOTIC
CHROMOSOMES
With
∼65-kb
Deletion
Without
∼65-kb
Deletion
Chromosomes of Europeans:
Allele 215 26 10 23
Non-215 allele 30 32 63
Chromosomes of non-Europeans:
Allele 215 NA 6 5
Non-215 allele NA 13 16
NOTE.—NA  not available.
Haplotypes from cystinosis families, on the basis of
either three or six microsatellite markers, gave 325 in-
formative meioses for the region, which spans markers
D17S829 and D17S1828. For these families, a recom-
bination frequency of .0186 (6/325) between the two
markers was observed. Substitution of these data into
the formula gives ang1 pD  [1 (1 v) ] (1 pN)
estimate of ∼63.5 generations (95% confidence interval
[CI] 29–73), since the deletion first arose on the chro-
mosome carrying the 215-bp allele and, assuming 25
years per generation, this suggests the deletion arose on
this background ∼1,580 years ago (95% CI 725–4, 325).
Detection of Junction Fragments
To determine the deletion breakpoints, we studied
DNA from our first cohort of patients, whose STS con-
tent had been analyzed elsewhere. Southern blots con-
taining HindIII-digested DNA were hybridized with the
CTNS cDNA probe (see Subjects and Methods). DNA
from unaffected controls produced a band pattern con-
sistent with the known map of the cystinosis region,
including a doublet of 2.8 kb, which contains both the
3′ end of exon 12 and exon 4 (fig. 1A). In the DNA
from the 20 patients shown to be homozygous for the
large deletion by PCR analysis, the 9.9-kb and 11-kb
fragments corresponding to exons 1–3 and to exons
5–11 plus the 5′ end of exon 12, respectively, were ab-
sent, whereas a 2.8-kb band was present. This band is
likely to consist of the 3′ part of exon 12, whereas the
exon 4 part is probably missing. By contrast, a novel
6.6-kb fragment was detected in all cases. The detection
of this abnormal band in addition to the normal frag-
ments, in 19 other patients, confirmed that they were
heterozygously deleted, as indicated by haplotype anal-
ysis. Considering the 27 patients for whom deletions had
not been detected by PCR and haplotype analysis, all
displayed the normal hybridization pattern. Finally, hy-
bridization of the CTNS probe to a Southern blot con-
taining the HindIII-digested DNA of patient P11 de-
tected the normal 2.8- and 11-kb fragments as well as
the 6.6-kb junction fragment, whereas the normal 9.9-
kb fragment was absent. This pattern is in agreement
with a large deletion on one allele and a smaller one,
encompassing only exons 1–3, on the other allele (fig.
1B), indicating that this patient was compound hetero-
zygous for two different deletions and not homozygous
for the small deletion, as suggested by STS content
analysis.
Identification of the Proximal and Distal Deletion
Breakpoints
By PCR amplification and long-range sequencing
across the breakpoints of the major CTNS deletions, a
356 Am. J. Hum. Genet. 65:353–359, 1999
Figure 2 Deletion breakpoint junctions. A, Restriction enzyme map of PAC clone K03130 (thin horizontal bar). HindIII (above) and
BamHI (below) sites are indicated (vertical lines). Random subclones derived from this PAC and used as a source of genomic sequence are
shown below (thick numbered lines). ESTs (AA099495, T85505, AA313583, and U90913) are indicated by arrows. The 12 CTNS exons are
indicated by blackened boxes with their respective number above each box. The regions containing the ∼65-kb and the P11 deletion breakpoints
are enlarged in triangles above and below, respectively, the map. The breakpoint positions are indicated by arrowheads. Alu, MIR, and L2
repeats are indicated by dotted, blackened, and hatched arrows, respectively. B, Nucleotide sequences of normal and deleted alleles. The asterisks
(*) indicate the nucleotide matches. The one base of overlap (C) at the ∼65-kb deletion junction is indicated in bold. The short direct repeats
are underlined, and the 11-bp insertion, as well as the homologous sequence in the normal sequence, are shaded.
fine map of the region could be constructed as shown
in fig. 2A.
Large Deletion.—By studying the STS content of the
regions spanned by the deletions, we previously mapped
the 5′ breakpoint of the large deletion between the end
of cosmid clone C11155 (marker C11155L) and the end
of P1 artificial chromosome (PAC) K03130 subclone 2
(Town et al. 1998). Both of these genomic clones con-
tain expressed sequence tags (ESTs) (AA099495 and
T85505, respectively), which, in turn, contain sequences
homologous to Alu repeats. We have amplified by PCR
and sequenced the intervening 1764 bp between the two
ESTs. This region contains two Alu repeats, at nucleotide
positions 299–580 and 1590–1763, and part of an L2
sequence of the LINE family at position 744–1338. The
3′ breakpoint was mapped elsewhere between exons 10
and 11. PCR amplification and sequencing showed that
the CTNS intron 10 is 1681 bp in length and contains
a repeat sequence of the MIR family at nucleotide po-
sition 1168–1275. We designed primers located in non-
repeated regions (primers 65A–65A.1), outside the de-
letion boundaries, which amplify a 1.25-kb bridging
fragment in patients with homozygous deletions but
which do not give a PCR product with control DNA.
The 1.25-kb product of five patients was sequenced in
its entirety and was compared with the sequence of the
respective 5′ and 3′ normal segments. This comparison
showed that the 5′ deletion breakpoint is located in the
L2 repeat, 994/995 bp downstream of the EST clone
AA099495, whereas the 3′ deletion breakpoint is actu-
ally located within an exon, 4–5 bp before the 3′ end of
exon 10. No sequence homology was detected between
the 5′ and 3′ sequences flanking the breakpoints, and
each breakpoint junction showed only a 1-bp overlap,
suggesting an end-joining mechanism (fig. 2B).
P11 Deletion.—For the small deletion found in family
P11, the 5′ breakpoint was mapped to the 5-kb PAC
K03130 subclone 5, whereas the 3′ breakpoint was
mapped to PAC K03130 subclone 49, which contains
the microsatellite D17S829. A 2.15-kb PCR product
spanning the breakpoint junction was amplified from
patient P11’s DNA, with the use of two primers located
in the nondeleted regions of PAC K03130 subclones 5
and 49. Direct sequencing of the PCR product and com-
parison with the normal sequences showed that the 3′
deletion breakpoint is located within intron 3, 1832 bp
downstream of the end of exon 3, in the stretch of GT
repeats of marker D17S829. This marker is framed by
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Figure 3 Segregation of the ∼65-kb deletion and the small P11
deletion in family P11. The two affected sibs (blackened squares) dis-
play an amplification product with the primer sets 65A–65A.1 and
65A–65A.2, both of which detect the ∼65-kb deletion, and with the
P11 primers, which detect the smaller deletion but do not display any
amplification product with D17S829, which is located within both
deletions. Their carrier sister as well as the cystinosis carriers of the
paternal branch display an amplification product with the P11 primers,
indicating that they are heterozygous for the small deletion, whereas
all the cystinosis carriers of the maternal branch display amplification
products with the primers 65A–65A.1 and 65A–65A.2, indicating that
they are heterozygous for the ∼65-kb deletion. Heterozygous carriers
and normal individuals have been determined by the measurement of
leukocyte cystine content and haplotype analysis (Jean et al. 1996).
several repeat sequences, one MIR repeat and one Alu
repeat, which are, respectively, 103–246 bp and
314–618 bp downstream of the breakpoint, and an Alu
repeat 726–417 bp upstream of the breakpoint. There
is also a single Alu repeat 202–496 bp downstream of
the 5′ breakpoint. No sequence homology around the
junction was detected. An 11-bp insertion was found at
the breakpoint junction of the deletion. This sequence
is homologous to the sequence 20–10 bp upstream of
the 5′ breakpoint but is located in the reverse orientation.
Additionally, two copies of a short direct GGGT repeat
were found 3 and 1 nucleotides away from the insertion
(fig. 2B). Given the location of the breakpoints and the
knowledge of the precise size of the PAC K03130 sub-
clones from sequencing data, we were able to estimate
the size of the P11 deletion to 13 kb.
PCR Deletion Test
To provide a more robust PCR deletion test, we used
the genomic sequence around the ∼65-kb deletion break-
point junction to design another set of primers
(65A–65A.2) that amplify a smaller, 360-bp bridging
fragment. Similarly, we also designed a set of primers,
P11.1–P11.2, that amplify a 755-bp fragment containing
the breakpoint of the small deletion.
All the 67 unrelated cystinotic individuals of our first
group were screened by PCR with the primers of the
marker D17S829 and the three sets of breakpoint prim-
ers (65A–65A1 and 65A–65A2 for the large deletion
and P11.1–P11.2 for the small deletion). In all cases
except that of patient P11, the DNA of patients with
homozygous or heterozygous deletions for the ∼65 kb
produced an amplification product with primers
65A–65A1 and 65A–65A2, but not with the primers
P11.1–P11.2. The amplification of a fragment from all
three sets of breakpoint primers with the DNA of patient
P11 confirmed the presence of both deletions in this
individual. No fragment was obtained, either with the
primer sets 65A–65A.1 and 65A–65A.2 or with
P11.1–P11.2, by amplification of the DNA of the 27
patients without deletions. To prove the robustness of
the PCR test with primers 65A–65A.2 and to demon-
strate that the ∼65-kb deletion was present on both al-
leles of the patients with homozygous deletions, we
tested the segregation of the deletion in 10 families (61
unaffected individuals) for which the heterozygous car-
rier status had been determined for 34 individuals by
leukocyte cystine content measurement and haplotype
analysis (Jean et al. 1996). As expected, the 360-bp de-
letion fragment was present in each patient and in every
heterozygous carrier but was not found in the 27 un-
affected, noncarrier relatives. For family P11, amplifi-
cation products were obtained with the sets of primers
65A–65A.1 and 65A–65A.2 in the maternal carriers and
with P11.1–P11.2 in the paternal carriers (fig. 3).
We then used the PCR assay to test DNA from our
second cohort of 80 patients who had not been previ-
ously analyzed. DNA was tested by PCR with the primer
sets 65A–65A.2 and P11.1–P11.2 and with the
D17S829 primers. No PCR product was obtained with
the primers P11.1–P11.2 in any case. In 35 affected in-
dividuals, no PCR product was obtained with the
D17S829 primers, whereas a 360-bp fragment was ob-
tained with the primers 65A–65A.2, indicating that these
individuals had homozygous deletions. Twenty-one dis-
played amplification products with both sets of primers
(D17S829 and 65A–65A2), indicating that they had het-
erozygous deletions. Twenty-four gave a PCR fragment
with D17S829, whereas no PCR fragment was detected
for the primers 65A–65A.2, indicating the absence of
the ∼65-kb deletion. To confirm that there was no het-
erozygous deletion that could have been missed by PCR,
we verified by Southern blot hybridization that all 24
patients did not display the 6.6-kb junction fragment.
When results were taken from both cohorts of patients,
among the 147 unrelated patients, 55 (37.4%) were ho-
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mozygous and 41 (27.9%) were heterozygous for the
large ∼65-kb deletion. Of the 24 patients of non-Eu-
ropean origin, only two, from North Africa, carried the
deletion. This raises to 76% the percentage of cystinotic
patients homozygous or heterozygous for the ∼65-kb
deletion in the European population.
Discussion
We have shown that deletions of the CTNS gene are
the most frequent mutations underlying nephropathic
cystinosis, and we have detected two types of deletions
on the basis of STS content analysis—a large deletion
(∼65 kb) found in all families but one and a smaller one
(9.5–16 kb) found in only one family (Town et al. 1998).
These results have been confirmed by Shotelersuk et al.
(1998), in an American-based population of cystinotic
patients. The authors found that 50 of 108 patients, all
of European descent, had homozygous deletions, with
48 of them probably bearing the ∼65-kb deletion, as
deduced by STS content. The present study reports the
characterization of the breakpoints of the two deletions
that we identified elsewhere. The breakpoints occur in
regions containing several repetitive elements either from
Alu, MIR, or LINE2 families (Smit 1996) but do not
involve unequal recombination between two of them.
The small deletion junction contains an 11-bp insertion
homologous to the sequence 20–10 bp upstream of the
5′ breakpoint but located in the reverse orientation, sug-
gesting complex reorganization at the deletion junction.
The large ∼65-kb deletion appears to represent a clean
breakage and reunion event with one nucleotide ho-
mology at the junction. These two types of deletion junc-
tions—insertional junctions and junctions exhibiting
limited amounts of homology (one to six nucleo-
tides)—have already been found in various hereditary
diseases (Henthorn et al. 1990; Woods-Samuels et al.
1991), indicating that nonhomologous recombination
events underlie the mechanism of the deletions associ-
ated with cystinosis. Contrary to the recombination be-
tween homologous regions giving rise to recurrent re-
arrangements (Lakich et al. 1993), this mechanism
favors the possibility of a founder effect for the muta-
tion. This hypothesis is strengthened by the demonstra-
tion of an identical breakpoint in all cases. Actually, we
have shown that the breakpoint sequence is strictly iden-
tical in the five unrelated patients for whom we se-
quenced the breakpoint and that the PCR product span-
ning the breakpoint has the same size in all patients and
in all available parent DNA of children with homozy-
gous deletions, ruling out the possibility of a larger de-
letion in one allele. Our data support the recent work
of Anikster et al. (1999), in which an identical break-
point sequence was confirmed in 24 different chromo-
somes of cystinotic patients. All the patients bearing the
mutation, to date, are white; hence, a founder effect
probably occurred in a white individual. To test this
hypothesis, we looked for a common haplotype flanking
the CTNS locus. Although we were not able to detect
strong linkage disequilibrium between the CTNS dele-
tion and any haplotype across the region, we did observe
that one allele of markerD17S1828was overrepresented
in the deleted chromosomes, as compared with the con-
trol chromosomes. This allowed us to date the mutation,
although the low number of patients (mainly affecting
precise evaluation of the recombination distance be-
tween D17S829 and D17S1828) leads to a broad 95%
CI. It can be inferred, however, from our data, that the
deletion event probably took place in the middle of the
first millenium AD. This is in agreement with the esti-
mation provided by Shotelersuk et al. (1998), who pro-
posed, on the basis of the family history of their cystin-
otic patients of European descent, that the deletion may
have initially occurred in Germany prior to 700 A.D.
The hypothesis of the deletion having arisen in northern
Europe and having spread throughout Europe toward
northern Africa is consistent with a north to south gra-
dient as found for the DF508 cystic fibrosis mutation
(Estivill et al. 1997) or a1-antitrypsin deficiency (Cox
1995). However, the existence of such a gradient is dif-
ficult to assess from our relatively small sample of pa-
tients from southern Europe and northern Africa and
will be confirmed only when a larger cohort of patients
from various countries is tested.
We have described here a useful and simple test for
the diagnosis of cystinosis. A similar study (Anikster et
al. 1999) has been done that determined the breakpoint
sequence of the large deletion. This study suggested the
use of a multiplex PCR-based assay as a diagnostic test
for patients carrying the large deletion. However, the
potential problems of unequal amplification of different
fragments, inherent in multiplex PCR, were recognized
by the authors themselves. To amplify the deletion
breakpoint junction, we successively designed two sets
of primers, amplifying fragments of 1.25 kb and 360
bp, respectively, and have shown, by comparison with
Southern blot and haplotype analysis, that both of them
are reliable, since they give equivalent results. Therefore,
we propose the use of the primers amplifying the 360-
bp fragment (65A–65A.2) for the detection of the break-
point deletion. Thus, by combining data from just two
PCRs, one using the primers corresponding to the
D17S829 marker located within the deletion and the
other a set of primers spanning the ∼65-kb deletion
breakpoint junction, we were able to detect both ho-
mozygous and heterozygous deletions in individuals
with nephropathic cystinosis. A high proportion (76%)
of the European patients carry a large deletion, and we
anticipate that this will be true of the general European
population. Therefore, multiplex or simplex PCR-based
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methodology will provide the basis for a rapid molecular
diagnostic test for cystinosis in Europe and for patients
of European descent in other countries. In particular, it
will be very useful for prenatal diagnosis and for detec-
tion of carrier individuals in affected families, as well as
for diagnosis of new cases.
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